Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-557-8 | CAS number: 354-33-6
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
HFC-125 was assessed for the potential to be metabolised to trifluoroacetic acid in liver, in comparison with other halogenated-ethanes. Male Fisher rats were exposed to halothane, HCFC-124, HFC-125, HCFC-123 and HFC-134a. At the end of the exposure, animals were placed in metabolism cages and urinary trifluoroacetic acid excretion was measured. The presence of trifluoroacetylated-hepatic protein was assessed by means of SDS-PAGE and immunoblotted with anti-TFA-protein serum. The potential to form trifluoroacetylated-hepatic protein has the following decreasing order: Halothane >= HCFC-123 >> HCFC-124 > HFC-125. TFA-proteins were not detected in samples from rats exposed to HFC-134a. 19F-NMR analysis of urinary TFA excretion confirmed the previous order of reactivity. The increased fluorination on the dihalomethyl group (-CX2H) decreases the metabolism of these compounds in vivo. HFC-125 showed a lower potential to form TFA in liver when compared to other halogenated ethanes.
Sprague Dawley rats were exposed to 1,000, 5,000 and 50,000 ppm (4,900, 24,500 and 245,000 mg/m3) HFC-125 for 6 hours in individual inhalation chambers (Anders, 1993). Absorption was calculated by measuring the decrease of HFC-125 concentration in atmosphere within the period of exposure. Results indicated a slight uptake at the end of the exposure period. Due to the low absorption of HFC-125, kinetic constants of uptake and metabolism were not calculated.
Conclusion
HFC-125 is very poorly absorbed via inhalation. Compared with other hydrofluorocarbons or hydrochlorofluorocarbons, HFC-125 is less likely to be metabolised to TFA in the liver or will be metabolized at a slower rate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
